Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Heidland, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 116 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Heidland, A; Gerabek, W; Sebekova, K
      Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension

      JOURNAL OF HUMAN HYPERTENSION
    2. Xiang, GS; Schinzel, R; Simm, A; Munch, G; Sebekova, K; Kasper, M; Niwa, T; Schmitz, C; Heidland, A
      Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 issuppressed by a protease in the tubule cell line LLC-PK1

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    3. Heidland, A; Sebekova, K; Schinzel, R
      Advanced glycation end products and the progressive course of renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    4. Wagner, Z; Wittmann, I; Mazak, I; Schinzel, R; Heidland, A; Kientsch-Engel, R; Nagy, J
      N-epsilon-(carboxymethyl)lysine levels in patients with type 2 diabetes: Role of renal function

      AMERICAN JOURNAL OF KIDNEY DISEASES
    5. Stopper, H; Boullay, F; Heidland, A; Vienken, J; Bahner, U
      Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    6. Xiang, GS; Schinzel, R; Simm, A; Sebekova, K; Heidland, A
      Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin

      KIDNEY INTERNATIONAL
    7. Sebekova, K; Blazicek, P; Syrova, D; Krivosikova, Z; Spustova, V; Heidland, A; Schinzel, R
      Circulating advanced glycation end product levels in rats rapidly increasewith acute renal failure

      KIDNEY INTERNATIONAL
    8. Krivosikova, Z; Dusinska, M; Spustova, V; Sebekova, K; Blazicek, P; Heidland, A; Dzurik, R
      DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan

      KIDNEY INTERNATIONAL
    9. Schinzel, R; Munch, G; Heidland, A; Sebekova, K
      Advanced glycation end products in end-stage renal disease and their removal

      NEPHRON
    10. Teschner, M; Heidland, A
      Reduced intrarenal protein degradation as a potential mediator of glomerulosclerosis and tubulo-interstitial fibrosis

      MEDIZINISCHE KLINIK
    11. Gerdemann, A; Lemke, HD; Nothdurft, A; Heidland, A; Munch, G; Bahner, U; Schinzel, R
      Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis

      CLINICAL NEPHROLOGY
    12. Bahner, U; Sebekova, K; Heidland, A
      Chronic metabolic acidosis - are the clinical consequences underestimated?

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    13. Heidland, A; Bahner, U; Vamvakas, S
      Incidence and spectrum of dialysis-associated cancer in three continents

      AMERICAN JOURNAL OF KIDNEY DISEASES
    14. Toigo, G; Aparicio, M; Attman, PO; Cano, N; Cianciaruso, B; Engel, B; Fouque, D; Heidland, A; Teplan, V; Wanner, C
      Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2)

      CLINICAL NUTRITION
    15. Toigo, G; Aparicio, M; Attman, PO; Cano, N; Cianciaruso, B; Engel, B; Fouque, D; Heidland, A; Teplan, V; Wanner, C
      Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2)

      CLINICAL NUTRITION
    16. Wardelmann, E; Ling, H; Heim, I; Schlebusch, H; Heidland, A; Pfeifer, U
      Influence of NH4Cl on polarized release of endogenous protein degradation products and on morphology in LLC-PK1 cells

      AMERICAN JOURNAL OF NEPHROLOGY
    17. Paczek, L; Pazik, J; Bartlomiejczyk, I; Gradowska, L; Lao, M; Rowinski, W; Szmidt, J; Heidland, A
      Chronic kidney allograft rejection is accompanied by increased urinary excretion of fibronectin

      TRANSPLANTATION PROCEEDINGS
    18. Sebekova, K; Heidland, A; Waidheim, A; Schinzel, R
      Evidence for accumulation of advanced glycation end products in acute renal failure

      NEPHRON
    19. Paczek, L; Kropiewnicka, EH; Bartlomiejczyk, I; Gradowska, L; Heidland, A; Wood, G
      Systemic proteolytic enzyme treatment diminishes urinary interleukin 6 in diabetic patients

      NEPHRON
    20. Huang, SM; Schaefer, RM; Reisch, S; Paczek, L; Schaefer, L; Teschner, M; Sebekova, K; Heidland, A
      Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis

      KIDNEY & BLOOD PRESSURE RESEARCH
    21. Sebekova, K; Schinzel, R; Munch, G; Krivosikova, Z; Dzurik, R; Heidland, A
      Advanced glycation end-product levels in subtotally nephrectomized rats: Beneficial effects of angiotensin II receptor 1 antagonist losartan

      MINERAL AND ELECTROLYTE METABOLISM
    22. Sebekova, K; Dammrich, J; Krivosikova, Z; Heidland, A
      The effect of oral protease administration in the rat remnant kidney model

      RESEARCH IN EXPERIMENTAL MEDICINE
    23. Stopper, H; Meysen, T; Bockenforde, A; Bahner, U; Heidland, A; Vamvakas, S
      Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy

      AMERICAN JOURNAL OF KIDNEY DISEASES
    24. Matzkies, FK; Bahner, U; Teschner, M; Hohage, H; Heidland, A; Schaefer, RM
      Efficiency of 1-year treatment with fluvastatin in hyperlipidemic patientswith nephrotic syndrome

      AMERICAN JOURNAL OF NEPHROLOGY
    25. Krivosikova, Z; Dusinska, M; Sebekova, K; Spustova, V; Heidland, A; Dzurik, R
      DNA damage in lymphocytes in experimental chronic renal failure-beneficialeffects of losartan

      NEOPLASMA
    26. KOKOT F; HEIDLAND A
      PROFESSOR ORLOWSKI,TADEUSZ, 80 YEARS - OBITUARY

      Nephrology, dialysis, transplantation
    27. WALDEGGER S; STEUER S; RISLER T; HEIDLAND A; CAPASSO G; MASSRY S; LANG F
      MECHANISMS AND CLINICAL-SIGNIFICANCE OF CELL-VOLUME REGULATION

      Nephrology, dialysis, transplantation
    28. HEIDLAND A; KIRIJAKOV Z; SIEBERTH HG
      REPORT OF THE SEMINAR UPDATE IN NEPHROLOGY AND HYPERTENSION IN SOFIA (BULGARIA)

      Nephrology, dialysis, transplantation
    29. SCHENK O; LING H; SEBEKOVA K; VAMVAKAS S; HEIDLAND A
      HIGH-GLUCOSE MEDIA ENHANCE THE RESPONSIVENESS OF TUBULAR CELLS TO GROWTH PROMOTERS - EFFECT ON LYSOSOMAL CATHEPSINS AND PROTEIN-DEGRADATION

      Mineral and electrolyte metabolism
    30. VAMVAKAS S; TESCHNER M; BAHNER U; HEIDLAND A
      ALCOHOL-ABUSE - POTENTIAL ROLE IN ELECTROLYTE DISTURBANCES AND KIDNEY-DISEASES

      Clinical nephrology
    31. HEIDLAND A; KOPPEL JD; MASSRY SG
      RITZ,EBERHARD - A NEPHROLOGY SCHOLAR AND POLYMATH

      American journal of nephrology
    32. PACZEK L; NOWACZYK M; KLEPACKA J; GRADOWSKA L; LAO M; GACIONG Z; GORSKI A; HEIDLAND A
      ABNORMAL ADHESION OF T-CELLS TO EXTRACELLULAR-MATRIX PROTEINS IN HEMODIALYSIS-PATIENTS

      American journal of nephrology
    33. VAMVAKAS S; BAHNER U; HEIDLAND A
      CANCER IN END-STAGE RENAL-DISEASE - POTENTIAL FACTORS INVOLVED

      American journal of nephrology
    34. Sebekova, K; Dammrich, J; Fierlbeck, W; Krivosikova, Z; Paczak, L; Heidland, A
      Effect of chronic therapy with proteolytic enzymes on hypertension-inducedrenal injury in the rat model of Goldblatt hypertension

      AMERICAN JOURNAL OF NEPHROLOGY
    35. SEBEKOVA K; SCHINZEL R; LING H; SIMM A; XIANG GS; GEKLE M; MUNCH G; VAMVAKAS S; HEIDLAND A
      ADVANCED GLYCATED ALBUMIN IMPAIRS PROTEIN-DEGRADATION IN THE KIDNEY PROXIMAL TUBULES CELL-LINE LLC-PK1

      Cellular and molecular biology
    36. LING H; ARDJOMAND P; SAMVAKAS S; SIMM A; BUSCH GL; LANG F; SEBEKOVA K; HEIDLAND A
      MESANGIAL CELL HYPERTROPHY INDUCED BY NH4CL - ROLE OF DEPRESSED ACTIVITIES OF CATHEPSINS DUE TO ELEVATED LYSOSOMAL PH

      Kidney international
    37. Bahner, U; Heidland, A
      Acetylsalicyclic acid in renal insufficiency

      INTERNIST
    38. VAMVAKAS S; MEYSEN T; STOPPER H; HEIDLAND A
      INCREASED FREQUENCY OF SPONTANEOUS LYMPHOCYTE MICRONUCLEI IN PATIENTSWITH CHRONIC-RENAL-FAILURE

      Journal of the American Society of Nephrology
    39. SEBEKOVA K; DAMMRICH J; PACZEK L; FIERLBECK W; KRIVOSIKOVA Z; GACIONG Z; HEIDLAND A
      HYPERTENSION-INDUCED RENAL INJURY - AMELIORATION BY PROTEOLYTIC-ENZYMES

      Journal of the American Society of Nephrology
    40. PACZEK L; GACIONG Z; BARTLOMIEJCZYK I; GRADOWSKA L; HEIDLAND A
      ADMINISTRATION OF PROTEASES DECREASES TRANSFORMING-GROWTH-FACTOR-BETA(TGF-BETA) CONTENT IN GLOMERULI FROM RATS WITH STREPTOZOTOCIN-INDUCEDDIABETES-MELLITUS (DM)

      Journal of the American Society of Nephrology
    41. MUNCH G; KEIS R; WESSELS A; RIEDERER P; BAHNER U; HEIDLAND A; NIWA T; LEMKE HD; SCHINZEL R
      DETERMINATION OF ADVANCED GLYCATION END-PRODUCTS IN SERUM BY FLUORESCENCE SPECTROSCOPY AND COMPETITIVE ELISA

      European journal of clinical chemistry and clinical biochemistry
    42. HEIDLAND A; RITZ E
      PROFESSOR DR STEIN,GUNTER (JENA)

      Nephrology, dialysis, transplantation
    43. RITZ E; HEIDLAND A
      STEIN,GUNTER CELEBRATES HIS 60TH BIRTHDAY

      Medizinische Klinik
    44. WALDEGGER S; BUSCH GL; KABA NK; ZEMPEL G; LING H; HEIDLAND A; HAUSSINGER D; LANG F
      EFFECT OF CELLULAR HYDRATION ON PROTEIN-METABOLISM

      Mineral and electrolyte metabolism
    45. SEBEKOVA K; PACZEK L; DAMMRICH J; LING H; SPUSTOVA V; GACIONG Z; HEIDLAND A
      EFFECTS OF PROTEASE THERAPY IN THE REMNANT KIDNEY MODEL OF PROGRESSIVE RENAL-FAILURE

      Mineral and electrolyte metabolism
    46. SEBEKOVA K; DAEMMRICH J; PACZEK L; GACIONG Z; BLAZICEK P; SPUSTOVA V; HEIDLAND A
      AMELIORATION OF THE PROGRESSIVE COURSE OF CHRONIC-RENAL-FAILURE IN SUBTOTALLY NEPHRECTOMIZED RATS BY INTRAPERITONEAL ENZYME THERAPY

      Nieren- und Hochdruckkrankheiten
    47. SEBEKOVA K; DAMMRICH J; FIERLBECK W; KRIVOSIKOVA Z; PACZEK L; HEIDLAND A
      SYSTEMIC TREATMENT WITH PROTEOLYTIC-ENZYMES IN RAT MODELS OF NONIMMUNE MEDIATED RENAL DISEASES

      International journal of immunotherapy
    48. HEIDLAND A; SEBEKOVA K; PACZEK L; TESCHNER M; DAMMRICH J; GACIONG Z
      RENAL FIBROSIS - ROLE OF IMPAIRED PROTEOLYSIS AND POTENTIAL THERAPEUTIC STRATEGIES

      Kidney international
    49. VAMVAKAS S; BAHNER U; HEIDLAND A
      INCREASED INCIDENCE OF CANCER IN END-STAG E RENAL-DISEASE - POTENTIALPATHOGENETIC MECHANISMS

      Schweizerische medizinische Wochenschrift
    50. SIMM A; MUNCH G; SEIF F; SCHENK O; HEIDLAND A; RICHTER H; VAMVAKAS S; SCHINZEL R
      ADVANCED GLYCATION ENDPRODUCTS STIMULATE THE MAP-KINASE PATHWAY IN TUBULUS CELL-LINE LLC-PK1

      FEBS letters
    51. PACZEK L; KROLAK R; BARTLOMIEJCZYK I; GRADOWSKA L; LAO M; GACIONG Z; HEIDLAND A
      URINARY-EXCRETION OF TRANSFORMING GROWTH-FACTOR-BETA AND INTERLEUKIN-6 IN THE COURSE OF DIABETIC NEPHROPATHY

      Journal of the American Society of Nephrology
    52. KEIS R; MUNCH G; BAHNER U; HEIDLAND A; THOME J; LEMBKE H; SCHINZEL R
      DETERMINATION OF ADVANCED GLYCATION ENDPRODUCTS (AGE) IN THE SERUM OFPATIENTS ON HEMODIALYSIS BY FLUORESCENCE SPECTROSCOPY

      Journal of the American Society of Nephrology
    53. KEIS R; MUNCH G; BAHNER U; HEIDLAND A; THOME J; LEMKE HD; GUNTHER C; SCHINZEL R
      DETERMINATION BY FLUORESCENCE SPECTROSCOPY OF ADVANCED GLUCATION ENDPRODUCTS (AGE) IN THE SERUM OF PATIENTS ON HEMODIALYSIS

      Journal of the American Society of Nephrology
    54. GACIONG Z; PAZEK L; BOJAKOWSKI K; WISNIEWSKI M; LAO M; HEIDLAND A
      TREATMENT WITH PROTEOLYTIC-ENZYMES INHIBITS VASCULAR ALLOGRAFT-REJECTION IN RATS

      Journal of the American Society of Nephrology
    55. LING H; VAMVAKAS S; GEKLE M; SCHAEFER L; TESCHNER M; SCHAEFER RM; HEIDLAND A
      ROLE OF LYSOSOMAL CATHEPSIN ACTIVITIES IN CELL HYPERTROPHY INDUCED BYNH4CL IN CULTURED RENAL PROXIMAL TUBULE CELLS

      Journal of the American Society of Nephrology
    56. DISTLER A; HEIDLAND A; STEIN G
      SEMINARS IN NEPHROLOGY AND HYPERTENSION IN EASTERN-EUROPE - ACTIVITIES OF THE KURATORIUM-DER-GESELLSCHAFT-FUR-NEPHROLOGIE

      Nephrology, dialysis, transplantation
    57. GACIONG Z; PACZEK L; BOJAKOWSKI K; SOCHA K; WISNIEWSKI M; HEIDLAND A
      BENEFICIAL EFFECT OF PROTEASES ON ALLOGRAFT ARTERIOSCLEROSIS IN A RATAORTIC MODEL

      Nephrology, dialysis, transplantation
    58. HEIDLAND A; KOKOT F; KOPPLE JD
      MASSRY,SHAUL,G., LOS-ANGELES, USA

      Nephrology, dialysis, transplantation
    59. KOPPLE JD; MASSRY SG; BERGSTROM J; ALVESTRAND A; HEIDLAND A
      NUTRITION AND METABOLISM IN RENAL-DISEASE - PROCEEDINGS OF THE 7TH INTERNATIONAL-CONFERENCE ON RENAL NUTRITION AND METABOLISM, STOCKHOLM, SWEDEN, MAY 29 JUNE 1, 1994 - INTRODUCTION

      Mineral and electrolyte metabolism
    60. PACZEK L; TESCHNER M; SCHAEFER RM; LAO M; GRADOWSKA L; HEIDLAND A
      LOW-DENSITY-LIPOPROTEIN SUPPRESSES CATHEPSIN-B AND CATHEPSIN-L ACTIVITY IN RAT MESANGIAL CELLS

      Mineral and electrolyte metabolism
    61. SCHMID G; BAHNER U; PESCHKES J; HEIDLAND A
      NEUROTRANSMITTER AND MONOAMINERGIC AMINO-ACID PRECURSOR LEVELS IN RAT-BRAIN - EFFECTS OF CHRONIC-RENAL-FAILURE AND OF MALNUTRITION

      Mineral and electrolyte metabolism
    62. HEIDLAND A; LING H; VAMVAKAS S; PACZEK L
      IMPAIRED PROTEOLYTIC ACTIVITY AS A POTENTIAL CAUSE OF PROGRESSIVE RENAL-DISEASE

      Mineral and electrolyte metabolism
    63. SCHAEFER L; MEIER K; HAFNER C; TESCHNER M; HEIDLAND A; SCHAEFER RM
      PROTEIN RESTRICTION INFLUENCES GLOMERULAR MATRIX TURNOVER AND TUBULARHYPERTROPHY BY MODULATION OF RENAL PROTEINASE ACTIVITIES

      Mineral and electrolyte metabolism
    64. SCHRAMM L; HEIDBREDER E; LOPAU K; SCHAAR J; ZIMMERMANN J; HARLOS J; TESCHNER M; LING H; HEIDLAND A
      INFLUENCE OF NITRIC-OXIDE ON RENAL-FUNCTION IN TOXIC ACUTE-RENAL-FAILURE IN THE RAT

      Mineral and electrolyte metabolism
    65. SCHAEFER L; MALCHOW M; SCHAEFER RM; LING H; HEIDLAND A; MASSRY SG
      EFFECTS OF PARATHYROID-HORMONE ON RENAL TUBULAR PROTEINASES

      Mineral and electrolyte metabolism
    66. KOKOT F; STEIN G; MOLZAHN M; HEIDLAND A
      THE 2ND POLISH-GERMAN SYMPOSIUM IN NEPHROLOGY AND HYPERTENSION - PREFACE

      Clinical nephrology
    67. PACZEK L; SOIN J; BARTLOMIEJCZYK I; KROLAK R; LAO M; GRADOWSKA L; HEIDLAND A
      IMPAIRMENT OF PROTEOLYTIC ACTIVITY IN ISOLATED GLOMERULI AND TUBULES IN EXPERIMENTAL DIABETIC NEPHROPATHY

      Clinical nephrology
    68. LING H; HEIDLAND A
      GROWTH PROMOTER-INDUCED INHIBITION OF PROTEOLYTIC ACTIVITIES IN CULTURED KIDNEY-CELLS - POTENTIAL IMPACT IN DIABETIC NEPHROPATHY

      Clinical nephrology
    69. GACIONG Z; PACZEK L; BOJAKOWSKI K; SOCHA K; WISNIEWSKI M; LIETZ K; LAO M; HEIDLAND A
      PROTEASE THERAPY ALLEVIATES ALLOGRAFT ARTERIOSCLEROSIS IN RATS

      Transplantation proceedings
    70. PACZEK L; BARTLOMIEJCZYK I; GRADOWSKA L; ROWINSKI; SZMIDT J; GACIONG Z; LAO M; HEIDLAND A
      INTRAGLOMERULAR PROTEIN ACCUMULATION IN CHRONICALLY REJECTED HUMAN KIDNEY ALLOGRAFTS

      Transplantation proceedings
    71. VAMVAKAS S; BAHNER U; BECKER P; STEINLE A; GOTZ R; HEIDLAND A
      IMPAIRMENT OF DNA-REPAIR IN THE COURSE OF LONG-TERM HEMODIALYSIS AND UNDER CYCLOSPORINE IMMUNOSUPPRESSION AFTER RENAL-TRANSPLANTATION

      Transplantation proceedings
    72. THOME J; MUNCH G; MULLER R; SCHINZEL R; KORNHUBER J; BLUMDEGEN D; SITZMANN L; ROSLER M; HEIDLAND A; RIEDERER P
      ADVANCED GLYCATION ENDPRODUCTS - ASSOCIATED PARAMETERS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH ALZHEIMERS-DISEASE

      Life sciences
    73. PALKOVITS M; MEZEY E; FODOR M; GANTEN D; BAHNER U; GEIGER H; HEIDLAND A
      NEUROTRANSMITTERS AND NEUROPEPTIDES IN THE BARORECEPTOR REFLEX ARC - CONNECTIONS BETWEEN THE NUCLEUS OF THE SOLITARY TRACT AND THE VENTROLATERAL MEDULLA-OBLONGATA IN THE RAT

      Clinical and experimental hypertension
    74. LING H; VAMVAKAS S; BUSCH G; LANG F; HEIDLAND A
      TRANSFORMING GROWTH-FACTOR BETA-1-INDUCED INHIBITION OF CATHEPSIN ACTIVITIES AND PROTEIN BREAKDOWN IS MEDIATED BY A RISE OF LYSOSOMAL PH AND AN INACTIVATION OF PROTEIN-KINASE-C IN CULTURED TUBULE CELLS

      Journal of the American Society of Nephrology
    75. LING H; VAMVAKAS S; BUSCH G; ARDJOMAND P; LANG F; HEIDLAND A
      MESANGIAL CELL HYPERTROPHY INDUCED BY NH4CL - KEY ROLE OF DEPRESSED ACTIVITIES OF CATHEPSINS DUE TO ELEVATED LYSOSOMAL PH

      Journal of the American Society of Nephrology
    76. HEIDLAND A; SEBEKOVA K; LING H
      EFFECT OF LOW-PROTEIN DIETS ON RENAL-DISEASE - ARE NONHEMODYNAMIC FACTORS INVOLVED

      Nephrology, dialysis, transplantation
    77. LING H; VAMVAKAS S; SCHAEFER L; SCHNITTLER HJ; SCHAEFER RM; HEIDLAND A
      ANGIOTENSIN-II-INDUCED CELL HYPERTROPHY - POTENTIAL ROLE OF IMPAIRED PROTEOLYTIC ACTIVITY IN CULTURED LLC-PK1 CELLS

      Nephrology, dialysis, transplantation
    78. SCHAEFER L; LORENZ T; DAEMMRICH J; HEIDLAND A; SCHAEFER RM
      ROLE OF PROTEINASES IN RENAL HYPERTROPHY AND MATRIX ACCUMULATION

      Nephrology, dialysis, transplantation
    79. RITZ E; KUSTER S; SCHMIDTGAYK H; STEIN G; SCHOLZ C; KRAATZ G; HEIDLAND A
      LOW-DOSE CALCITRIOL PREVENTS THE RISE IN 1,84 IPTH WITHOUT AFFECTING SERUM-CALCIUM AND PHOSPHATE IN PATIENTS WITH MODERATE RENAL-FAILURE (PROSPECTIVE PLACEBO-CONTROLLED MULTICENTER TRIAL)

      Nephrology, dialysis, transplantation
    80. HEIDLAND A; SCHINDLER G; FRANKE S
      ACUTE-RENAL-FAILURE FOLLOWING HIGH INTRAVENOUS DOSES OF NAFTIDROFURYLOXALATE

      Nephrology, dialysis, transplantation
    81. LING H; VAMVAKAS S; BUSCH G; DAMMRICH J; SCHRAMM L; LANG F; HEIDLAND A
      SUPPRESSING ROLE OF TRANSFORMING GROWTH-FACTOR-BETA-1 ON CATHEPSIN ACTIVITY IN CULTURED KIDNEY TUBULE CELLS

      American journal of physiology. Renal, fluid and electrolyte physiology
    82. DEETJEN A; HEIDLAND A; PANGERL A; MEYERSABELLEK W; SCHAEFER RM
      ANTIHYPERTENSIVE TREATMENT WITH A VASODILATING BETA-BLOCKER, CARVEDILOL, IN CHRONIC-HEMODIALYSIS PATIENTS

      Clinical nephrology
    83. LING H; VAMVAKAS S; SCHAEFER L; SCHRAMM L; PACZEK L; DAEMMRICH J; SCHAEFER RM; HEIDLAND A
      DOSE-DEPENDENT STIMULATION-INHIBITION EFFECTS OF CYCLOSPORINE-A ON LYSOSOMAL CATHEPSIN ACTIVITIES IN CULTURED PROXIMAL TUBULE CELLS

      Research in experimental medicine
    84. LING H; VAMVAKAS S; TESCHNER M; SCHAEFER RM; SCHAEFER L; SCHRAMM L; HEIDLAND A
      ROLE OF ANGIOTENSIN-II ON PROTEOLYTIC ACT IVITY IN CULTURED RENAL-CELLS

      Nieren- und Hochdruckkrankheiten
    85. SCHRAMM L; HEIDBREDER E; KARTENBENDER K; SCHMITT A; ZIMMERMANN J; LOPAU K; LING H; HEIDLAND A
      EFFECTS OF URODILATIN AND DILTIAZEM ON RENAL-FUNCTION IN ISCHEMIC ACUTE-RENAL-FAILURE IN THE RAT

      American journal of nephrology
    86. SUZUKI H; SCHAEFER L; LING H; SCHAEFER RM; DAMMRICH J; TESCHNER M; HEIDLAND A
      PREVENTION OF CARDIAC-HYPERTROPHY IN EXPERIMENTAL CHRONIC-RENAL-FAILURE BY LONG-TERM ACE-INHIBITOR ADMINISTRATION - POTENTIAL ROLE OF LYSOSOMAL PROTEINASES

      American journal of nephrology
    87. KOKOT F; WIECEK A; SCHMIDTGAYK H; MARCINKOWSKI W; GILGE U; HEIDLAND A; RUDKA R; TREMBECKI J
      FUNCTION OF ENDOCRINE ORGANS IN HEMODIALYZED PATIENTS OF LONG-TERM ERYTHROPOIETIN THERAPY

      Artificial organs
    88. LING H; VAMVAKAS S; SCHAEFER L; OLDAKOWSKAJEDYNAK U; TESCHNER M; SCHAEFER RM; HEIDLAND A
      SUPPRESSING ROLE OF TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) ONPROTEINASE ACTIVITY IN CULTURED TUBULE CELLS - POTENTIAL ROLE OF PROTEIN-KINASE-C

      Kidney international
    89. LING H; VAMVAKAS S; GEKLE M; SCHAEFER L; TESCHNER M; SCHAEFER RM; HEIDLAND A
      THE ROLE OF LYSOSOMAL CYSTEINE PROTEINASES IN CELLULAR HYPERTROPHY INDUCED BY NH4CL IN CULTURED RENAL TUBULE CELLS (LLC-PK1)

      Kidney international
    90. KOKOT F; WIECEK A; HEIDLAND A; SCHMIDTGAYK H; KUCZERA M; KIERSZTEJN M
      ENDOCRINE FUNCTION OF THE ISCHEMIC KIDNEY

      Kidney international
    91. SCHAEFER L; SCHAEFER RM; HEIDLAND A
      GLOMERULAR PROTEINASE ACTIVITIES IN STREPTOZOTOCINDIABETIC AND OBESE ZUCKER RATS

      Kidney international
    92. PACZEK L; PAZIK J; GRADOWSKA L; SENATORSKI G; LAO M; BARTLOMIEJCZYK I; HEIDLAND A; ROWINSKI W; SZMIDT J
      INTRAGLOMERULAR CATHEPSIN-B AND CATHEPSIN-L ACTIVITY IN CHRONIC KIDNEY ALLOGRAFT-REJECTION

      Transplantation proceedings
    93. LING H; VAMVAKAS S; SCHAEFER L; SCHAEFER RM; TESCHNER M; SCHRAMM L; HEIDLAND A
      INSULIN-LIKE GROWTH-FACTOR-I INDUCED REDUCTION IN CYSTEINE PROTEINASEACTIVITY IN FRESHLY ISOLATED PROXIMAL TUBULE CELLS OF THE RAT

      Nephron
    94. RITZ E; KUSTER S; SCHMIDTGAUK H; STEIN G; SCHOLZ C; KRAATZ G; HEIDLAND A
      LOW-DOSE CALCITRIOL PREVENTS THE RISE IN 1,84 IPTH WITHOUT AFFECTING SERUM-CALCIUM AND PHOSPHATE - PROSPECTIVE PLACEBO-CONTROLLED MULTICENTER TRIAL

      Journal of the American Society of Nephrology
    95. LING H; VAMVAKAS S; SCHAEFER L; OLDAKOWSKAJEDYNAK U; TESCHNER M; SCHAEFER RM; HEIDLAND A
      SUPPRESSING ROLE OF TRANSFORMING GROWTH FACTOR-BETA(1) ON PROTEINASE ACTIVITY IN CULTURED TUBULE CELLS - POTENTIAL ROLE OF PROTEIN-KINASE-C

      Journal of the American Society of Nephrology
    96. LING H; VAMVAKAS S; GEKLE M; SCHAEFER L; TESCHNER M; SCHAEFER RM; HEIDLAND A
      THE ROLE OF LYSOSOMAL CYSTEINE PROTEINASES IN CELLULAR HYPERTROPHY INDUCED BY NH4CL IN CULTURED RENAL TUBULE CELLS (LLC-PK1)

      Journal of the American Society of Nephrology
    97. HEIDLAND A; MASSRY SG
      JAHN,HENRI (1923-1994) - OBITUARY

      Nephrology, dialysis, transplantation
    98. SCHRAMM L; HEIDBREDER E; LOPAU K; SCHAAR J; DECICCO D; GOTZ R; HEIDLAND A
      TOXIC ACUTE-RENAL-FAILURE IN THE RAT - EFFECTS OF L-ARGININE AND N-METHYL-L-ARGININE ON RENAL-FUNCTION

      Nephrology, dialysis, transplantation
    99. SCHRAMM L; HEIDBREDER E; SCHMITT A; KARTENBENDER K; ZIMMERMANN J; LING H; HEIDLAND A
      ROLE OF L-ARGININE-DERIVED NO IN ISCHEMIC ACUTE-RENAL-FAILURE IN THE RAT

      Renal failure
    100. KULZER P; SCHAEFER RM; KRAHN R; SCHAEFER L; HEIDLAND A; FRIEDBERG D; STEFFENSEN G; PASTERNAK A; JAHN H; MERY JP; EDEL H; GRABENSEE B; KRAUSE DW; TEMMINGHOFF M; DAHL K; SALTVEDT E; FAUCHALD P; LINDHOLM T; LUNDBERG M
      EFFECTIVENESS AND SAFETY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO)IN THE TREATMENT OF ANEMIA OF CHRONIC-RENAL-FAILURE IN NON DIALYSIS PATIENTS

      International journal of artificial organs


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 22:12:26